Skip to content

Clinical trials

Phase 3 Dyslipidemias trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyslipidemias Phase: Phase 3 Country / region: France Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20052
20063
20071
20101
20121
20131
20141
20173
20211
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated5
Active, not recruiting2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen4
Solvay Pharmaceuticals4
Novartis Pharmaceuticals3
Takeda2
89bio, Inc.1
Boehringer Ingelheim1
Centre Hospitalier Universitaire, Amiens1
Hoffmann-La Roche1
Kowa Research Institute, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyslipidemias18
Hypercholesterolemia6
Hyperlipidemias6
Glucose Metabolism Disorders4
Cardiovascular Diseases3
Diabetes Mellitus, Type 22
Aortic Valve Stenosis1
Atherosclerosis1
Coronary Artery Disease1
Coronary Disease1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.